B. J. Meyer

A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19

J. Justman, Jasmine Schwartz, E. Hod, 2021, medRxiv.

Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

J. Justman, E. Hod, W. Lipkin, 2020, Trials.

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

W. Lipkin, T. Briese, N. Mishra, 2020, Trials.

Characteristics and Palliative Care Needs of COVID‐19 Patients Receiving Comfort‐Directed Care

C. Blinderman, Jihae Lee, Jonah L Tischler, 2020, Journal of the American Geriatrics Society.

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

J. Justman, E. Hod, W. Lipkin, 2020, Trials.

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

D. Brodie, J. Claassen, M. Baldwin, 2020, The Lancet.

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

D. Brodie, J. Claassen, M. Baldwin, 2020, medRxiv.